What is Transluminal Technologies?
Transluminal Technologies is a medical device company focused on developing and commercializing advanced closure technologies. Their flagship products, such as the velox CD and velox LB, are engineered from bioabsorbable magnesium alloy, offering a novel approach to medical closures. These devices are designed for rapid, secure, and user-friendly application within healthcare settings, aiming to enhance patient care and procedural efficiency. The company's innovation targets medical institutions and professionals seeking superior alternatives to traditional closure methods.
How much funding has Transluminal Technologies raised?
Transluminal Technologies has raised a total of $1.5M across 1 funding round:
Private Equity
$1.5M
Private Equity (2013): $1.5M, investors not publicly disclosed
What's next for Transluminal Technologies?
The recent major strategic investment positions Transluminal Technologies for accelerated growth and market penetration. This capital infusion is expected to fuel further research and development, expand manufacturing capabilities, and bolster commercialization efforts for their unique bioabsorbable magnesium alloy closure devices. The company's focus on improving patient outcomes through advanced medical technology suggests a trajectory towards becoming a key player in the specialized medical device market, potentially leading to further enterprise-level funding rounds as they scale operations and broaden their product adoption.
See full Transluminal Technologies company page
